A Phase 1 Study of Ciraparantag for Reversal of Anticoagulation

Terminated Phase 2 NCT04593784

Study Description

A Study to Evaluate the Effectiveness and Safety of Ciraparantag in Reversing the Effects of Blood Thinners in Healthy Adults

Study Details

Registry ID:: NCT04593784
Conditions:: Healthy
Phase:: Phase 2
Target Enrollment:: 41 participants
Start Date:: October 13, 2021
Healthy Volunteers:: No

Study Locations (3 sites)

Qps-Mra, Llc.
South Miami, FloridaUnited States, United States
Frontage Clinical Services
Secaucus, New JerseyUnited States, United States
ICON Early Phase Services, LLC
San Antonio, TexasUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →